Catalyst Event
CME Group Inc (CME) · Other
From KEDI U.S. Dividend100 90% Participation + Daily Options Premium Index (KUSDV100P)
3/23/2026, 12:00:00 AM
Filed a definitive proxy statement on 2026-03-23 including a proposal to eliminate Class B shareholder election rights. Market impact estimated at 5% due to significant governance changes.
Korean Translation
2026년 3월 23일, 클래스 B 주주 이사 선출권 폐지 안건 포함 위임장 제출함. 지배구조 변경에 따른 5% 수준의 주가 영향 예상됨.
Related Recent Events
Target Corp (TGT) · Earnings Release
Q1 2026 earnings release scheduled for 2026-05-20 scheduled.
5/20/2026, 12:00:00 AM
Amgen Inc (AMGN) · Other
A quarterly dividend of $2.52 per share for Q2 2026 is scheduled, with an ex-dividend date of May 15, 2026; a price impact of ≥1% is estimated due to the routine nature of the distribution, scheduled.
5/15/2026, 12:00:00 AM
Williams Cos Inc. (The) (WMB) · Earnings Release
Q1 2026 earnings release is scheduled for 2026-05-04. Earnings releases typically result in a price impact of at least 5%. Analysts forecast EPS of approximately $0.62-$0.63 forecasted.
5/4/2026, 12:00:00 AM
Merck and Co Inc (MRK) · Earnings Release
Merck is scheduled to release its Q1 2026 financial results before the market opens. Earnings releases typically cause significant price volatility, justifying a Medium importance, scheduled.
4/30/2026, 12:00:00 AM
Conocophillips (COP) · Earnings Release
First quarter 2026 earnings release and conference call scheduled for April 30, 2026; ≥1% price impact estimated upon release, scheduled.
4/30/2026, 12:00:00 AM
United Parcel Service Inc (UPS) · Earnings Release
Q1 2026 earnings release scheduled. Medium importance is assigned as earnings releases typically cause price volatility exceeding 5%.
4/28/2026, 12:00:00 AM